Sustainable Smart Polymer Composite Materials: A Comprehensive Review

This review provides a thorough analysis of the progress made in smart polymer composite materials, which have recently been seen as potential game-changers in areas such as construction, aerospace, biomedical engineering, and energy. This article emphasizes the distinctive characteristics of these materials, including their responsiveness to stimuli like temperature, light, and pressure, and their potential uses in different industries. This paper also examines the difficulties and restrictions associated with the creation and utilization of smart polymer composite materials. This review seeks to provide a thorough understanding of smart polymer composite materials and their potential to offer innovative solutions for a variety of applications

Cardiac Sarcoidosis: When and How to Treat Inflammation

Sarcoidosis is a complex, multisystem inflammatory disease with a heterogeneous clinical spectrum. Approximately 25% of patients with systemic sarcoidosis will have cardiac involvement that portends a poorer outcome. The diagnosis, particularly of isolated cardiac sarcoidosis, can be challenging. A paucity of randomised data exist on who, when and how to treat myocardial inflammation in cardiac sarcoidosis. Despite this, corticosteroids continue to be the mainstay of therapy for the inflammatory phase, with an evolving role for steroid-sparing and biological agents. This review explores the immunopathogenesis of inflammation in sarcoidosis, current evidence-based treatment indications and commonly used immunosuppression agents. It explores a multidisciplinary treatment and monitoring approach to myocardial inflammation and outlines current gaps in our understanding of this condition, emerging research and future directions in this field

Exfoliation and physico-chemical characterization of novel bioplasticizers from Nelumbo nucifera leaf for biofilm application

Due to the extreme threats as environmental and health issues caused by the petroleum-based leachable plasticizers, researchers among different domains are more interested in finding unique biodegradable plasticizers from natural sources. The present study used Nelumbo nucifera leaf to extract novel biopolymers as viable substitutes for chemical plasticizers. The biopolymers extraction was carried out through chemical means and its physico-chemical and morphological characterization were carried out to confirm its plastic nature. The polymers extracted possess a low glass transition temperature (77.17 °C), good thermal stability (230 °C), low density (0.94 g/cc), good surface roughness (34.154 μm), low crystallinity index (25.1%) and moderate crystallite size (16.36 nm). The presence of an organic polymer with specific chemical groups as olefinic alkenes, epoxide, imino/azo groups, and hydrophobic organic siloxane groups, signify that the material is a condensed phenolic derivative. Furthermore, bio-film was formulated using NLP and poly lactic acid (PLA) matrix to evaluate its plasticizing effect and film-forming ability. Variation in specific properties of film was noted after bio-plasticizer addition, where tensile strength (20.94 ± 1.5 MPa to 19.22 ± 1.3 MPa) and Young's modulus (1.462 ± 0.43 GPa to 1.025 ± 0.52 GPa) was found to be decreased whereas increased the percentage of elongation at break (26.30 ± 1.1% to 39.64 ± 1.6%). In addition, decreased glass transition temperature (Tg) (59.17 °C), good surface compatibility, and increased flexibility of NLP-PLA film in contrast to pure PLA film authorizes the plasticizing effect of bio-plasticizers on PLA. Since the extracted bio-plasticizers could be a suitable replacement to harmful synthetic plasticizers for lightweight packaging applications in bioplastics sector

Sustainable Smart Polymer Composite Materials: A Comprehensive Review

This review provides a thorough analysis of the progress made in smart polymer composite materials, which have recently been seen as potential game-changers in areas such as construction, aerospace, biomedical engineering, and energy. This article emphasizes the distinctive characteristics of these materials, including their responsiveness to stimuli like temperature, light, and pressure, and their potential uses in different industries. This paper also examines the difficulties and restrictions associated with the creation and utilization of smart polymer composite materials. This review seeks to provide a thorough understanding of smart polymer composite materials and their potential to offer innovative solutions for a variety of applications

Functional testing, coronary artery calcifications, and outcomes in Hodgkin lymphoma survivors treated with chest radiation

Abstract Background Consensus guidelines recommend periodic screening for coronary artery disease (CAD) in Hodgkin lymphoma (HL) survivors treated with radiation therapy (RT) to the chest. However, the prognostic utility of screening strategies in this population remains unclear. We evaluated the association between functional testing, coronary artery calcifications (CAC), and guideline-based risk assessment and major adverse cardiovascular events (MACE) in HL survivors treated with RT. Methods We retrospectively studied HL survivors treated with RT who underwent functional testing between 2003 and 2020 and chest computed tomography (CT) within 12 months of each other at our center. CAC was assessed semi-quantitatively from CT images. Cardiovascular risk was estimated using the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Diagnostic test characteristics were calculated using major adverse cardiac events (MACE) during follow-up as the gold standard. Results The study included 159 patients (median age at functional testing 48 years, median age at HL diagnosis 27 years, 62.9% female). Abnormal functional testing had the highest specificity (94.2% (95% CI 88.4%-97.6%)) and positive likelihood ratio (4.55 (95% CI 1.86–11.13)) while CAC had the highest sensitivity (63.2% (95% CI 46.0%-78.2%)) and lowest negative likelihood ratio (0.52 (95% CI 0.34–0.80)). Specificity for ACC/AHA risk assessment was also high (88.5% (95% CI 81.1%-93.7%)). Over 3.3 years of follow-up, abnormal functional testing (adjusted subdistribution hazard ratio (SHR) 5.10, 95% CI 2.41 – 10.78, p < 0.001) and CAC (adjusted SHR 3.58, 95% CI 1.35 – 9.47, p = 0.010) were both significantly associated with MACE. Conclusions In HL survivors treated with RT, both abnormal functional testing and ACC/AHA risk assessment had high specificity for subsequent MACE, but CAC had higher sensitivity. Further research is needed to inform CAD screening and primary prevention strategies in this population

Management of Coronary Artery Calcium and Coronary CTA Findings

Coronary artery calcium (CAC) testing and coronary computed tomography angiography (CTA) have significant data supporting their ability to identify coronary artery disease (CAD) and classify patient risk for atherosclerotic cardiovascular disease (ASCVD). Evidence regarding CAC use for screening has established an excellent prognosis in patients with no detectable CAC, and the ability to risk re-classify the majority of asymptomatic patients considered intermediate risk by traditional risk scores. While data regarding the ideal management of CAC findings are limited, evidence supports statin consideration in patients with CAC > 0 and individualized aspirin therapy accounting for CAD risk factors, CAC severity, and factors which increase a patient’s risk of bleeding. In patients with stable or acute symptoms undergoing coronary CTA, a normal CTA predicts excellent prognosis, allowing reassurance and disposition without further testing. When CTA identifies nonobstructive CAD (<50 % stenosis), observational data support consideration of statin use/intensification in patients with extensive plaque (at least four coronary segments involved) and patients with high-risk plaque features. In patients with both nonobstructive and obstructive CAD, multiple studies have now demonstrated an ability of CTA to guide management and improve CAD risk factor control. Still, significant under-treatment of cardiovascular risk factors and high-risk image findings remain, among concerns that CTA may increase invasive angiography and revascularization. To fully realize the impact of atherosclerosis imaging for ASCVD prevention, patient engagement in lifestyle changes and the modification of ASCVD risk factors remain the foundation of care. This review provides an overview of available data and recommendations in the management of CAC and CTA findings